scholarly article | Q13442814 |
P356 | DOI | 10.1126/SCIENCE.2588007 |
P698 | PubMed publication ID | 2588007 |
P2093 | author name string | Bevilacqua MP | |
Rice GE | |||
P2860 | cites work | Identification of an inducible endothelial-leukocyte adhesion molecule | Q34381169 |
P433 | issue | 4935 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 1303-1306 | |
P577 | publication date | 1989-12-01 | |
P1433 | published in | Science | Q192864 |
P1476 | title | An inducible endothelial cell surface glycoprotein mediates melanoma adhesion | |
P478 | volume | 246 |
Q37588628 | "The air got to it:" exploring a belief about surgery for lung cancer |
Q40563721 | A Critical Role for P2X7 Receptor-Induced VCAM-1 Shedding and Neutrophil Infiltration during Acute Lung Injury |
Q36530133 | A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture |
Q68182963 | A YIGSR-containing novel mutein without the detrimental effect of human TNF-? of enhancing experimental pulmonary metastasis |
Q41724437 | A blocking monoclonal antibody to endothelial-leukocyte adhesion molecule-1 (ELAM1) |
Q71635308 | A novel in vitro assay system for transendothelial tumor cell invasion: significance of E-selectin and alpha 3 integrin in the transendothelial invasion by HT1080 fibrosarcoma cells |
Q41493019 | A novel soluble form of mouse VCAM-1 is generated from a glycolipid-anchored splicing variant |
Q72236623 | A simple fluorometric assay for quantifying the adhesion of tumour cells to endothelial monolayers |
Q28290419 | A single mRNA encodes the alpha 150 and alpha 80/70 forms of the alpha subunit of VLA4 |
Q24292864 | Activated endothelium binds lymphocytes through a novel binding site in the alternately spliced domain of vascular cell adhesion molecule-1 |
Q41466091 | Activation Dependent and Independent VLA-4 Binding Sites on Vascular Cell Adhesion Molecule-1 |
Q36367016 | Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. |
Q46937737 | Adhesion Molecules Involved in the Interaction of LGL/NK Cells and Human Endothelial Cells Stimulated with Salmonella Bacteria |
Q71635441 | Adhesion and penetration properties of human lymphocytes acting on allogeneic vascular endothelial cells |
Q37260250 | Adhesion between human neutrophils and immobilized endothelial ligand vascular cell adhesion molecule 1: divalent ion effects |
Q71647921 | Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticaria |
Q40615153 | Adhesion molecules and their role in cancer metastasis. |
Q35477814 | Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix |
Q42506069 | Adhesion molecules in normal human conjunctiva. An immunohistological study using monoclonal antibodies |
Q36368973 | Adhesive interactions in angiogenesis and metastatasis |
Q35830499 | Alternative splicing of human VCAM-1 in activated vascular endothelium |
Q41252667 | An E-selectin-IgG chimera supports sialylated moiety dependent adhesion of colon carcinoma cells under fluid flow |
Q71687614 | An in vitro invasion model for human renal cell carcinoma cell lines mimicking their metastatic abilities |
Q35164292 | Analyses of VLA-4 Structure and Function |
Q41040555 | Analysis of the expression of intercellular adhesion molecule-1 in cells of the human bronchial epithelial cell line NCI-H292. |
Q41493032 | Apoptosis in metastatic cancer cells |
Q40598967 | Are cellular adhesion molecules involved in the metastasis of breast cancer? |
Q41492858 | Arrangement of domains, and amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1). |
Q44077891 | Augmentation by tumor necrosis factor alpha of the systemic therapeutic effect of lymphokine-activated killer cells in adoptive immunotherapy of murine tumor |
Q72501841 | B16 melanoma cell spreading on activated endothelial cells |
Q40958442 | Biology of metastasis and its clinical implications: renal-cell cancer |
Q34219354 | Blocking of lung endothelial cell adhesion molecule-1 (Lu-ECAM-1) inhibits murine melanoma lung metastasis |
Q36056734 | CAMs and anti-CAMs. The clinical potential of cell adhesion molecules |
Q38297303 | CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins |
Q34324146 | CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. |
Q37548676 | CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. |
Q67464692 | Cancer cell binding to E-selectin transfected human endothelia |
Q35477829 | Cancer cell interactions with injured or activated endothelium |
Q40521030 | Cancer, immune function, and physical activity |
Q89603040 | Cancer-associated fibroblasts-derived VCAM1 induced by H. pylori infection facilitates tumor invasion in gastric cancer |
Q72254527 | Carbohydrate structures of recombinant soluble lamp-1 and leukosialin containing sialyl Le(x) terminus |
Q71749099 | Cell adhesion molecules acting between C6 glioma and endothelial cells |
Q34503793 | Cell adhesion molecules and oral cancer |
Q36135912 | Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence |
Q40594287 | Cell adhesion molecules in inflammation and immunity: relevance to periodontal diseases |
Q37253559 | Cell adhesion receptor expression during melanoma progression and metastasis |
Q40575372 | Cell biology of liver endothelial and Kupffer cells. |
Q35156008 | Cell interaction molecules and cytokines which participate in B lymphopoiesis |
Q40986836 | Cell surface antigens in leukemias and lymphomas |
Q40657043 | Cellular adhesion molecules. |
Q35002729 | Central mechanisms for autonomic dysreflexia after spinal cord injury |
Q77590694 | Chemokine production and adhesion molecule expression by neural cells exposed to IL-1, TNF alpha and interferon gamma |
Q61945789 | Circulating adhesion molecules during kidney allograft reperfusion |
Q36617374 | Circulating intercellular adhesion molecule 1 (ICAM-1), E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in head and neck cancer |
Q35976329 | Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. |
Q55476209 | Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and plasma thrombomodulin levels in glioblastoma patients. |
Q22010719 | Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens |
Q48123922 | Cloning and sequencing of mouse VCAM-1 cDNA |
Q43791678 | Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1) |
Q36695658 | Cloning of an inflammation-specific phosphatidyl inositol-linked form of murine vascular cell adhesion molecule-1 |
Q39637420 | Comparison of cell adhesion molecule expression in cutaneous leucocytoclastic and lymphocytic vasculitis |
Q39853350 | Computerized analysis of tumor cell interactions with extracellular matrix proteins, peptides, and endothelial cells under laminar flow |
Q36369274 | Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow |
Q33622596 | Constitutive expression of the alpha4 integrin correlates with tumorigenicity and lymph node metastasis of the B16 murine melanoma |
Q90676029 | Construction and characterization of human embryonic kidney-(HEK)-293T cell overexpressing truncated α4 integrin |
Q38309552 | Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis |
Q72078557 | Correlation of VLA-4 integrin expression with metastatic potential in various human tumour cell lines |
Q37624830 | Critical amino acid residues for ligand binding are clustered in a predicted beta-turn of the third N-terminal repeat in the integrin alpha 4 and alpha 5 subunits. |
Q40958445 | Current and future strategies to block tumor angiogenesis, invasion, and metastasis |
Q33559926 | Cytokine induction of VCAM-1 but not IL13Rα2 on glioma cells: a tale of two antibodies |
Q36383586 | Cytokine induction of an alternatively spliced murine vascular cell adhesion molecule (VCAM) mRNA encoding a glycosylphosphatidylinositol-anchored VCAM protein |
Q40832086 | Cytokines. 1. Overview |
Q35977896 | Decreased adhesion to endothelial cells and matrix proteins of H-2Kb gene transfected tumour cells |
Q73628976 | Detection of ICAM-1 in experimentally induced colitis of ICAM-1-deficient and wild-type mice: an immunohistochemical study |
Q34167171 | Determining force dependence of two-dimensional receptor-ligand binding affinity by centrifugation |
Q39143641 | Development of quinic acid-conjugated nanoparticles as a drug carrier to solid tumors |
Q58064819 | Differential expression of VLA-4 integrin by resident and peripheral blood B lymphocytes. Acquisition of functionally active α4β1-fibronectin receptors upon B cell activation |
Q36592980 | Differential role of an NF-κB transcriptional response element in endothelial versus intimal cell VCAM-1 expression. |
Q72079306 | Dimethyl sulfoxide (DMSO) increases expression of sialyl lewis X antigen and enhances adhesion of human gastric carcinoma (NUGC4) cells to activated endothelial cells |
Q72802807 | Distribution of blood-group-related carbohydrate antigens on oral endothelial cells |
Q34439087 | Divergent fates of P- and E-selectins after their expression on the plasma membrane |
Q30852491 | E-selectin can mediate the arrest type of adhesion of colon cancer cells under physiological shear flow |
Q41666703 | EA-1, a novel adhesion molecule involved in the homing of progenitor T lymphocytes to the thymus |
Q41714445 | ELAM-1 Mediates Cell Adhesion by Recognition of a Carbohydrate Ligand, Sialyl-Le x |
Q38338410 | ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA |
Q45194343 | Effect of antigen challenge on lymph node lymphocyte adhesion to vascular endothelial cells and the role of VLA-4 in the rat |
Q41932087 | Effect of mycophenolic acid on TNF alpha-induced expression of cell adhesion molecules in human venous endothelial cells in vitro |
Q36114813 | Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma |
Q73572254 | Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease |
Q55012033 | Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. |
Q48138953 | Emerging evidence for inflammation in conditions frequently affecting older adults: report of a symposium |
Q52046657 | Endothelial adhesion molecules for nasal-homing T cells in allergy. |
Q33910733 | Endothelial cell Ca2+ increases upon tumor cell contact and modulates cell-cell adhesion |
Q41139210 | Endothelial cell damage by Walker carcinosarcoma cells is dependent on vitronectin receptor-mediated tumor cell adhesion. |
Q40016208 | Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1 |
Q77333559 | Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor alpha-stimulated vascular endothelial cells |
Q78181050 | Enhanced expression of ELAM-1 on endothelium of renal cell carcinoma compared to the corresponding normal renal tissue |
Q36229960 | Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis |
Q38289196 | Expression and function of α2,3‐sialyl‐ and α,3/l,4‐fucosyltransferases in colon adenocarcinoma cell lines: Role in synthesis of E‐selectin counter‐receptors |
Q55483490 | Expression and ligand-binding function of the integrin alpha 4 beta 1 (VLA-4) on neural-crest-derived tumor cell lines |
Q49088319 | Expression of ICAM-1 in distant metastatic thyroid carcinoma |
Q71692419 | Expression of adhesion molecule ICAM-1 (CD54) in thyroid papillary adenocarcinoma |
Q33190433 | Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells |
Q41406343 | Expression of cell adhesion molecules in an established and characterized new human renal cell cancer line, CCF-RC7. |
Q67753695 | Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes |
Q36080089 | Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value |
Q35798248 | Expression of cell adhesion molecules on liver-associated lymphocytes and their ligands on sinusoidal lining cells in patients with benign or malignant liver disease |
Q35747047 | Expression of lysosome-associated membrane proteins in human colorectal neoplasms and inflammatory diseases |
Q41525251 | Expression of selectin ligands by cutaneous squamous cell carcinoma |
Q37341182 | Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis |
Q73111093 | Expression of vascular cell adhesion molecule-1 (VCAM-1) in the aortae of hypercholesterolemic rabbits with high (HAR) and low (LAR) atherosclerotic response |
Q41857345 | Expression of vascular cell adhesion molecule-1 in fibroblastlike synoviocytes after stimulation with tumor necrosis factor |
Q36232054 | Functional analysis of the human vascular cell adhesion molecule 1 promoter |
Q28288759 | Functional and structural analysis of VLA-4 integrin alpha 4 subunit cleavage |
Q80152805 | Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populations |
Q36657963 | GMP-140: A receptor for neutrophils and monocytes on activated platelets and endothelium |
Q37589196 | Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene |
Q34274788 | Gene transfer of α1,3‐fucosyltransferase increases tumor growth of the PC‐3 human prostate cancer cell line through enhanced adhesion to prostatic stromal cells |
Q30907649 | Glycosylated VCAM-1 isoforms revealed in 2D western blots of HUVECs treated with tumoral soluble factors of breast cancer cells |
Q36893367 | Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines |
Q37253585 | Growth factors in melanoma |
Q41592068 | HMEC-1: establishment of an immortalized human microvascular endothelial cell line |
Q37405861 | Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta |
Q24292848 | Higher-affinity oligosaccharide ligands for E-selectin |
Q41564510 | Homotypic leukocyte aggregation triggered by a monoclonal antibody specific for a novel epitope expressed by the integrin β1 subunit: Conversion of nonresponsive cells by transfecting human integrin α4 subunit cDNA |
Q41686645 | Human lung adenocarcinoma cell lines with different lung colonization potential (LCP), and a correlation between expression of sialosyl dimeric Lex (defined by MAb FH6) and LCP |
Q38317638 | Human vascular adhesion protein-1 in smooth muscle cells |
Q24306183 | Hypoxia up-regulated angiogenin and down-regulated vascular cell adhesion molecule-1 expression and secretion in human placental trophoblasts |
Q51755436 | ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas. |
Q34976406 | IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. |
Q41166993 | IL-1alpha gene-transfected human melanoma cells increase tumor-cell adhesion to endothelial cells and their retention in the lung of nude mice |
Q36229844 | Identification of a 107-kD glycoprotein that mediates adhesion between stromal cells and hematolymphoid cells |
Q41610898 | Identification of a human endothelial cell activation antigen that is co-expressed by germinal follicle centre B lymphocytes |
Q41975538 | Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29) |
Q38332063 | Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck |
Q33571085 | Imaging molecular expression on vascular endothelial cells by in vivo immunofluorescence microscopy |
Q41034842 | Importance of hepatic first-pass removal in metastasis of colon carcinoma cells |
Q40512176 | In vitro and in vivo activation of endothelial cells by colony-stimulating factors |
Q41594943 | In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands |
Q39319182 | Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancer |
Q36350921 | Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism |
Q35833674 | Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma |
Q35773877 | Induction of experimental bone metastasis in mice by transfection of integrin alpha 4 beta 1 into tumor cells. |
Q39512381 | Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. |
Q92522355 | Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation |
Q42840045 | Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin. |
Q38354491 | Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue |
Q35440540 | Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. |
Q38306877 | Inhibitory Effect of Recombinant Fibronectin Polypeptides on the Adhesion of Liver‐metastatic Lymphoma Cells to Hepatic Sinusoidal Endothelial Cells and Tumor Invasion |
Q58992474 | Integrin Signaling as a Cancer Drug Target |
Q36893104 | Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions |
Q41638856 | Integrin expression in human melanoma cells with differing invasive and metastatic properties |
Q37106353 | Integrin expression in malignant melanoma |
Q41110565 | Interaction of human malignant melanoma (ST-ML-12) tumor spheroids with endothelial cell monolayers. Damage to endothelium by oxygen-derived free radicals |
Q59675618 | Interaction of tumor cells with vascular endothelia: role of platelet-activating factor |
Q36670334 | Interactions between Endothelial Cells and the Cells of the Immune System |
Q72076953 | Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression |
Q34392868 | Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism |
Q38299475 | Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice |
Q42133183 | Laminin mediates tethering and spreading of colon cancer cells in physiological shear flow |
Q30437758 | Leukocyte adhesion molecules in animal models of inflammatory bowel disease |
Q35454934 | Leukocyte cell adhesion proteins: from molecular dissection to clinical applications |
Q40400310 | Leukocyte migration and adhesion. |
Q68073360 | Locally increased metastatic efficiency as a reason for preferential metastasis of solid tumors to lymph nodes |
Q24645961 | Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence |
Q36233008 | Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung-metastatic rat breast and prostate carcinoma cells |
Q36253257 | Lung metastases after liver resection or cryotherapy for hepatic metastasis from colorectal cancer--there is a difference! |
Q36231422 | Lymphocyte adhesion through very late antigen 4: evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule 1 and an additional alpha 4 integrin counter-receptor on stimulated endothelium |
Q35822759 | Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells |
Q41034837 | Mechanism of initial distribution of blood-borne colon carcinoma cells in the liver |
Q37611458 | Mediation of lung metastasis of murine melanomas by a lung-specific endothelial cell adhesion molecule |
Q36535834 | Modulation of the immune system by mammary tumor-derived factors |
Q40922417 | Molecular analysis of the physiological and pathophysiological role of alpha 4-integrins |
Q36080583 | Molecular cloning of a cell-surface glycoprotein that can potentially discriminate mesothelium from epithelium: its identification as vascular cell adhesion molecule 1. |
Q42767877 | Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium |
Q39519710 | Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells |
Q42799680 | Mucosal vascular addressin cell adhesion molecule-1 is expressed outside the endothelial lineage on fibroblasts and melanoma cells |
Q41579068 | Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1 |
Q36651682 | Multiple loop structures critical for ligand binding of the integrin alpha4 subunit in the upper face of the beta-propeller mode 1 |
Q36233314 | Mutation of putative divalent cation sites in the alpha 4 subunit of the integrin VLA-4: distinct effects on adhesion to CS1/fibronectin, VCAM-1, and invasin |
Q36369285 | Neonatally induced inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune response |
Q35832547 | Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation |
Q38858253 | New insights into the heterogeneity and functional diversity of human mesenchymal stem cells |
Q41139934 | New insights into tumor-host interactions in lymphoma metastasis |
Q37629655 | Nitric oxide inhibits hetero-adhesion of cancer cells to endothelial cells: restraining circulating tumor cells from initiating metastatic cascade. |
Q38037836 | Organ-preference of metastasis. The role of endothelial cell adhesion molecules |
Q34171030 | P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer |
Q37367437 | PMN adhesion and extravasation as a paradigm for tumor cell dissemination |
Q35763598 | Pannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions. |
Q40332005 | Phase I trial of metronomic oral vinorelbine in patients with advanced cancer |
Q35477800 | Platelets and cancer metastasis: a causal relationship? |
Q34451438 | Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion |
Q34706663 | Putative role of 67 kDa elastin-laminin receptor in tumor invasion |
Q40431920 | P‐Selectin Knockout: A Mouse Model for Various Human Diseases |
Q58571806 | Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins |
Q38338272 | Recognition by Elam-1 of the Sialyl-Le x Determinant on Myeloid and Tumor Cells |
Q36366262 | Redirection of tumor metastasis by expression of E-selectin in vivo |
Q41854663 | Regulated expression of vascular cell adhesion molecule-1 in human malignant melanoma |
Q67701914 | Regulation of Rransendothelial Neutrophil Migration by Endogenous Interleukin-8 |
Q40625609 | Regulation of endothelial cell adhesion molecule expression with antisense oligonucleotides |
Q41909450 | Regulation of the VLA integrin-ligand interactions through the beta 1 subunit |
Q36234074 | Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4 |
Q56431007 | Role of Microvascular Endothelial Cells in Inflammation |
Q71815116 | Role of N‐linked glycosylation in expression of E‐selectin on human endothelial cells |
Q35604780 | Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma |
Q35722958 | Role of keratinocytes in allergic contact dermatitis |
Q33910871 | Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions |
Q71481083 | Selectin ligands on human melanoma cells |
Q24602099 | Selectins |
Q74439190 | Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma |
Q74456291 | Serum cell adhesion molecules in patients with colorectal cancer |
Q80573279 | Serum soluble vascular cell adhesion molecule-1 (VCAM-1) concentrations in children with reflux nephropathy |
Q67702858 | Signaling by vascular cell adhesion molecule-1 (VCAM-1) through VLA-4 promotes CD3-dependent T cell proliferation |
Q36723325 | Simulation of cell rolling and adhesion on surfaces in shear flow. Microvilli-coated hard spheres with adhesive springs |
Q34091440 | Simulation of cell rolling and adhesion on surfaces in shear flow: general results and analysis of selectin-mediated neutrophil adhesion |
Q35172845 | Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological Significance |
Q78541986 | Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma |
Q34449122 | Specialized functional properties of the integrin alpha 4 cytoplasmic domain |
Q36956344 | Stepping out of the flow: capillary extravasation in cancer metastasis |
Q59076972 | Sticky sugars for selectins |
Q41682351 | Structural and Functional Studies of Full-Length Vascular Cell Adhesion Molecule-1: Internal Duplication and Homology to Several Adhesion Proteins |
Q40949680 | Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappaB independent pathway |
Q40419219 | The adhesion cascade and anti-adhesion therapy: an overview |
Q40388060 | The alpha 4 beta 1/VCAM-1 adhesion pathway in physiology and disease |
Q41547351 | The biochemistry of cancer dissemination |
Q34523324 | The chemistry of oligosaccharide ligands of selectins: significance for the development of new immunomodulatory medicines |
Q39785346 | The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand |
Q42492176 | The death domain of tumor necrosis factor receptor 1 is necessary but not sufficient for Golgi retention of the receptor and mediates receptor desensitization |
Q33959323 | The epidermal growth factor receptor in breast cancer. |
Q42466607 | The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation: a comparison of ultraviolet B erythema and delay |
Q33415704 | The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas |
Q40668566 | The importance of blood cell-vessel wall interactions in tumour metastasis |
Q37956452 | The invasive phenotypes |
Q58212449 | The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium |
Q43936142 | The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines |
Q28184466 | The role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion |
Q34294331 | The role of endothelial cells in tumor invasion and metastasis |
Q36530308 | The selectin GMP-140 binds to sialylated, fucosylated lactosaminoglycans on both myeloid and nonmyeloid cells |
Q35174972 | The selectin family of carbohydrate‐binding proteins: Structure and importance of carbohydrate ligands for cell adhesion |
Q58212481 | Tumor angiogenesis in node-negative breast carcinomas ? relationship with epidermal growth factor receptor, estrogen receptor, and survival |
Q36744271 | Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1 |
Q40394594 | Tumor invasion, proteolysis, and angiogenesis |
Q35838122 | Tumor lymphangiogenesis as a potential therapeutic target |
Q42108713 | Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration |
Q38319685 | Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. |
Q35764418 | Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses |
Q71791432 | Tumour-cell-endothelial interactions: free radicals are mediators of melanoma-induced endothelial cell damage |
Q45373225 | Up-regulation of the vascular cell adhesion molecule-1 (VCAM-1) induced by Theiler's murine encephalomyelitis virus infection of murine brain astrocytes |
Q58212211 | Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival |
Q92478420 | VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid Cancer |
Q36765584 | VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity |
Q40419264 | VLA-4 and lymphocyte trafficking in immune-inflammatory states: novel therapeutic approaches in allograft arteriopathy |
Q41955991 | VLA‐4 Molecules on Tumor Cells Initiate an Adhesive Interaction with VCAM‐1 Molecules on Endothelial Cell Surface |
Q35830751 | Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues |
Q41025705 | Vascular cell adhesion molecule 1 (CD106) on primary human articular chondrocytes: functional regulation of expression by cytokines and comparison with intercellular adhesion molecule 1 (CD54) and very late activation antigen 2. |
Q78024307 | Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking |
Q38207560 | Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis |
Q40339111 | Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis |
Q24324521 | Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells |
Q50791973 | Vascular cell adhesion molecule-1-targeted detection of endothelial activation in human microvasculature. |
Q70497287 | Very late antigen integrins are involved in the adhesive interaction of lymphoid cells to human gingival fibroblasts |
Q37982819 | What getting sick means |
Q36141188 | beta-1 Integrins mediate tumour cell adhesion to quiescent endothelial cells in vitro. |
Search more.